MORGAN STANLEY PLC/CALL/PFIZER INC/55.5/0.1/17.01.25 Stock

Warrant

DE000MB32GW2

Market Closed - Börse Stuttgart 02:28:36 2024-07-12 pm EDT
0.017 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/PFIZER INC/55.5/0.1/17.01.25
Current month+21.43%
1 month+54.55%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 0.017 0.00%
24-07-11 0.017 +6.25%
24-07-10 0.016 0.00%
24-07-09 0.016 0.00%
24-07-08 0.016 0.00%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 02:28 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB32GW
ISINDE000MB32GW2
Date issued 2023-02-01
Strike 55.5 $
Maturity 2025-01-17 (189 Days)
Parity 10 : 1
Emission price 0.29
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.25
Lowest since issue 0.007
Spread 0.023
Spread %57.50%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.92 USD
Average target price
32.1 USD
Spread / Average Target
+10.99%
Consensus